Cardiac resynchronization therapy: A cost or an investment?

Europace

Volumn 13, Issue SUPPL. 2, 2011, Pages

  Boriani, Giuseppe ^a   Mantovani, Lorenzo G ^b   Biffi, Mauro ^a   Schalij, Martin J ^c   Martignani, Cristian ^a   Leclercq, Christophe ^d   Bax, Jeroen J ^c   Auricchio, Angelo ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

Cost; Cost effectiveness; Cost utility; Health economics; Heart failure

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEFIBRILLATOR; FOLLOW UP; HEALTH CARE; HEALTH ECONOMICS; HEART FAILURE; HUMAN; INVESTMENT; PATIENT SELECTION; PRIORITY JOURNAL; UNITED STATES;

ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; EUROPE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INVESTMENTS; PREVALENCE; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 79955625822     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur079     Document Type: Article

References (38)

1. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007;28:2256-95. (Pubitemid 47428944)
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008;29:2388-442.
3. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Eur Heart J 2010;31:2677-87.
4. Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC et al. Pre-venting tomorrow's sudden cardiac death today: dissemination of effective thera- pies for sudden cardiac death prevention. Am Heart J 2008;156:613-22.
5. Matchar DB, Mark DB. Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(Suppl. 6):132S-40S. (Pubitemid 351892965)
6. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
7. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE trial. J Am Coll Cardiol 2009;54:1837-46.
8. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007;297:2502-14. (Pubitemid 46953404)
9. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008;5:646-53.
10. Boriani G, Diemberger I, Biffi M, Martignani C, Valzania C, Ziacchi M et al. Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization. J Interv Card Electrophysiol 2006;17:215-24. (Pubitemid 46626268)
11. Swedberg K, Cleland J, Cowie MR, Nieminen M, Priori SG, Tavazzi L et al. Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail 2008;10:1229-35.
12. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 2008;1:98-106.
13. Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT et al. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J 2009;158:956-64.
14. Boriani G, Rapezzi C, Diemberger I, Gonzini L, Gorini M, Lucci D et al. Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. J Eval Clin Pract 2010; 16:82-91.
15. Merkely B, Roka A, Kutyifa V, Boersma L, Leenhardt A, Lubinski A et al. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace 2010;12:692-701.
16. Meltzer MI. Introduction to health economics for physicians. Lancet 2001;358: 993-8. (Pubitemid 32913530)
17. Boriani G, Maniadakis N, Auricchio A, Vardas P. Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association. Europace 2010;12:601-3.
18. Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A et al. The European cardiac resynchronization therapy survey. Eur Heart J 2009;30:2450-60.
19. Joshi R, Jan S, Wu Y, MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol 2008;52:1817-25.
20. Boriani G, Biffi M, Martignani C, Diemberger I, Valzania C, Bertini M et al. Expenditure and value for money: the challenge of implantable cardioverter defibrillators. QJM 2009;102:349-56.
21. Eichler HG, Kong SX, Gerth WC, Mavros P, Jönsson B. Use of costeffectiveness analysis in health-care resource allocation decision-making: how are costeffectiveness thresholds expected to emergefi Value Health 2004;7:518-28.
22. Appleby J, Devlin N, Parkin D. NICE's cost effectiveness threshold. BMJ 2007;335: 358-9. (Pubitemid 47359304)
23. http://www.who.int/choice/costs/CER-thresholds/en/index.html
24. Nichol G, Kaul P, Huszti E, Bridges JF. Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure. Ann Intern Med 2004;141: 343-51.
25. Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2311-21. (Pubitemid 41785503)
26. Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. Eur Heart J 2005;26:2681-8. (Pubitemid 41746691)
27. Banz K, on behalf of the Eucomed CRT Steering Committee. Cardiac resynchronization therapy (CRT) in heart failure - a model to assess the economic value of this new medical technology. Value Health 2005;8:128-39. (Pubitemid 40525374)
28. Fattore G, Landolina M, Bontempi L, Cacciatore G, Curnis A, Gulizia M et al. Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness. Ital Heart J Suppl 2005;6:796-803. (Pubitemid 44898627)
29. Caro JJ, Guo S, Ward A, Chalil S, Malik F, Leyva F. Modelling the economic and health consequences of cardiac resynchronization therapy in the UK. Curr Med Res Opin 2006;22:1171-9. (Pubitemid 44000737)
30. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007;28:42-51. (Pubitemid 46134956)
31. Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess 2007; 11:iii-iv, ix-248.
32. Bentkover JD, Dorian P, Thibault B, Gardner M. Economic analysis of a randomized trial of biventricular pacing in Canada. Pacing Clin Electrophysiol 2007;30: 38-43. (Pubitemid 46114927)
33. Aidelsburger P, Grabein K, Klauss V, Wasem J. Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective. Clin Res Cardiol 2008;97:89-97. (Pubitemid 351257992)
34. Blomström P, Ekman M, Lundqvist CB, Calvert MJ, Freemantle N, Lönnerholm S et al. Cost effectiveness of cardiac resynchronization therapy in the Nordic region: an analysis based on the CARE-HF trial. Eur J Heart Fail 2008;10:869-77.
35. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-90.
36. Bax JJ, Gorcsan J 3rd. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT study in perspective. J Am Coll Cardiol 2009;53:1933-43.
37. Boriani G, Diemberger I, Martignani C, Biffi M, Valzania C, Bertini M et al. Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med 2008;23(Suppl. 1):73-7. (Pubitemid 350301955)
38. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683-94.